2020
DOI: 10.3390/molecules25081934
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and Structure Insights of Two Novel Broad-Spectrum Antibacterial Candidates Based on (E)-N′-[(Heteroaryl)methylene]adamantane-1-carbohydrazides

Abstract: Two new N′-heteroarylidene-1-carbohydrazide derivatives, namely; E-N′-[(pyridine-3-yl)methylidene]adamantane-1-carbohydrazide (1) and E-N′-[(5-nitrothiophen-2-yl)methylidene]adamantane-1-carbohydrazide (2), were produced via condensation of adamantane-1-carbohydrazide with the appropriate heterocyclic aldehyde. Both compounds were chemically and structurally characterized by 1H-NMR, 13C-NMR, infrared and UV-vis spectroscopies, and single crystal X-ray diffraction. The study was complemented with density functi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
11
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 8 publications
(15 citation statements)
references
References 51 publications
4
11
0
Order By: Relevance
“…[ 188 ] As another example, hydrazone 210 (Figure 23) had broad‐spectrum antibacterial activity against Gram‐positive bacteria, but its antifungal activity was weak. [ 189 ] Hydrazone 211 (Figure 23) derived from a sulfonylhydrazine had poor antibacterial activity in an agar well diffusion test at 400 μg/well, but its anti‐ Candida activity was somewhat better (diameter of inhibition zone was 35% of that recorded for oxiconazole). [ 190 ] Despite being the most potent compound among its analogs with MICs as low as 125 μg/ml against several bacterial strains, hydrazone 212 (Figure 23) derived from another sulfonylhydrazine was nonetheless a very weak antibacterial agent compared to standard antibacterial drugs (e.g., tetracycline had MICs ranging from 0.025 to 0.625 μg/ml).…”
Section: Antimicrobial Compounds Derived From Thiophene‐2‐carboxaldeh...mentioning
confidence: 99%
“…[ 188 ] As another example, hydrazone 210 (Figure 23) had broad‐spectrum antibacterial activity against Gram‐positive bacteria, but its antifungal activity was weak. [ 189 ] Hydrazone 211 (Figure 23) derived from a sulfonylhydrazine had poor antibacterial activity in an agar well diffusion test at 400 μg/well, but its anti‐ Candida activity was somewhat better (diameter of inhibition zone was 35% of that recorded for oxiconazole). [ 190 ] Despite being the most potent compound among its analogs with MICs as low as 125 μg/ml against several bacterial strains, hydrazone 212 (Figure 23) derived from another sulfonylhydrazine was nonetheless a very weak antibacterial agent compared to standard antibacterial drugs (e.g., tetracycline had MICs ranging from 0.025 to 0.625 μg/ml).…”
Section: Antimicrobial Compounds Derived From Thiophene‐2‐carboxaldeh...mentioning
confidence: 99%
“…The anti-bacterial activity of organotin derivatives, including organotin carboxylates, is already welldocumented [33] so it seemed a natural step forward to evaluate the anti-bacterial potential of a variety of organotin species coupled with adamantane carboxylates. Further, broadspectrum anti-bacterial behaviour exhibited by adamantane-1-carbohydrazides in contrast to limited anti-fungal activity was ascribed to the lipophilic attributes of the molecules [81].…”
Section: Overview Of Anti-bacterial Assaysmentioning
confidence: 99%
“…According to experimental and molecular docking studies for the identification of chemical features of 11β-HSD1 inhibitors, a combination of an adamantane cage-and 1,2,4-triazole or other azole moieties could result in potent 11β-HSD1 inhibitors [15,16,[24][25][26][27][28][29]. In continuation with ongoing interest in the structural properties [30][31][32][33][34][35] and biological applications of adamantane-based derivatives [35][36][37][38][39], we report herein on the molecular structure insights, Hirshfeld surface analysis and pairwise interaction energies of three adamantane-linked 1,2,4-triazole N-Mannich bases, namely ethyl 4-[(3adamantan-1-yl)-4-ethyl-5-thioxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)methyl]piperazine-1carboxylate (1), 5-(adamantan-1-yl)-4-ethyl-2-[(4-(pyridin-2-yl)piperazin-1-yl)methyl]-2,4-dihydro-3H-1,2,4-triazole-3-thione (2) and 5-(adamantan-1-yl)-4-allyl-2-[(4-(pyridin-2yl)piperazin-1-yl)methyl]-2,4-dihydro-3H-1,2,4-triazole-3-thione (3), which were proven to possess marked hypoglycemic activity [39]. Molecular docking analyses at the 11β-HSD1 active site were also performed, in order to predict the potential 11β-HSD1 binding affinity and binding interactions of the compounds.…”
Section: Introductionmentioning
confidence: 99%